Search Results - "Pacenti, David"

Effect of Collection Tube Type and Preanalytical Handling on Myeloperoxidase Concentrations by Shih, Jessie, Datwyler, Saul A, Hsu, Stephen C, Matias, Matthew S, Pacenti, David P, Lueders, Christian, Mueller, Christian, Danne, Oliver, Mockel, Martin

“…Myeloperoxidase (MPO) has shown potential as a marker for cardiovascular disease. Limited studies have been published with a variety of sample types, resulting…”
Get full text

Potential interference by antineutrophil cytoplasmic autoantibodies in myeloperoxidase immunoassays by Datwyler, Saul A, Hsu, Stephen C, Matias, Matthew S, Pacenti, David P, Shih, Jessie

“…Antineutrophil cytoplasmic autoantibodies (ANCAs) are known to exist in patients with diseases characterized by primary systematic vasculitis, such as Wegener…”
Get full text

Mass spectrometric and physiological validation of a sensitive, automated, direct immunoassay for serum estradiol using the Architect by Sluss, Patrick M., Hayes, Frances J., Adams, Judith M., Barnes, Wayne, Williams, Gregg, Frost, Stephen, Ramp, John, Pacenti, David, Lehotay, Denis C., George, Sabu, Ramsay, Carol, Doss, Robert C., Crowley, William F.

“…Measurement of estradiol (E 2) plays a critical role in the diagnosis and clinical management of reproductive disorders. The challenge for all currently…”
Get full text

Development of an Abbott ARCHITECT cyclosporine immunoassay without metabolite cross-reactivity by Brate, Elaine M., Finley, David M., Grote, Jonathan, Holets-McCormack, Shelley, Ozaeta, Pan F., Pacenti, David, Peart, Joan E., Piktel, Ryan E., Ramsay, Carol S., Rupprecht, Kevin R., Saldana, Sylvia C., Spring, Thomas G., Tetin, Sergey Y., Trudeau, Beth C., Wang, Phil, Xie, Helen

“…We investigated the mechanism by which the ARCHITECT cyclosporine (CsA) chemiluminescent microparticle immunoassay (CMIA) eliminates cross-reactivity to CsA…”
Get full text